These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33968061)

  • 1. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.
    Jaén RI; Sánchez-García S; Fernández-Velasco M; Boscá L; Prieto P
    Front Immunol; 2021; 12():658840. PubMed ID: 33968061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxin Mimetics and the Resolution of Inflammation.
    Godson C; Guiry P; Brennan E
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():429-448. PubMed ID: 36662584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases.
    Andrews D; Godson C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158940. PubMed ID: 33839296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM; Serhan CN
    Braz J Med Biol Res; 2001 May; 34(5):555-66. PubMed ID: 11323741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxins: regulators of resolution.
    Ryan A; Godson C
    Curr Opin Pharmacol; 2010 Apr; 10(2):166-72. PubMed ID: 20226737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
    Serhan CN
    FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
    Lannan KL; Spinelli SL; Blumberg N; Phipps RP
    J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins in inflammation.
    Sachdeva S; Saluja H; Mani A; Phadnaik MB; Mani S
    Clin Hemorheol Microcirc; 2022; 82(3):201-216. PubMed ID: 35147530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing.
    Svensson CI; Zattoni M; Serhan CN
    J Exp Med; 2007 Feb; 204(2):245-52. PubMed ID: 17242163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of lipoxin A4 in central nervous system pathologies.
    Martini AC; Forner S; Bento AF; Rae GA
    Biomed Res Int; 2014; 2014():316204. PubMed ID: 25276776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
    Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
    Front Immunol; 2020; 11():1997. PubMed ID: 32983141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation.
    Recchiuti A; Isopi E; Romano M; Mattoscio D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.